You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Business & Finance
Perrigo Company announces USD0.26 per share dividend
4 November 2022 -

Perrigo Company plc (NYSE: PRGO), an American/Irish global provider of consumer self-care products, announced on Thursday a quarterly dividend of USD0.26 per share.

This amount is unchanged from the company's previous quarterly dividend.

It will be paid on 20 December 2022 to shareholders of record as of 2 December 2022.

Login
Username:

Password:


Related Headlines

iECURE Raises USD 65m to Advance In Vivo Gene Editing Programs for the Treatment of Rare Pediatric Liver Diseases

Enveric Biosciences Completes Confidential Submission of Registration Statement for the Spin-off of its Cannabinoid Business to Shareholders

Grünenthal, Kyowa Kirin Ink JV Collaboration for Established Medicines Portfolio

Medicure reports quarter ended 30 September 2022 financial results

Lemonex, IVI Exchange Agree to Jointly Develop Vaccines

Perrigo Company announces USD0.26 per share dividend

Amgen announces Q4 2022 dividend

Symeres announces acquisition of Exemplify BioPharma

Eli Lilly and Company announces dividend for fourth quarter of 2022

Biocorp and Merck KGaA, Darmstadt, Germany Partner on Smart Drug Delivery

BIOCORP and Germany's Merck sign smart drug delivery agreement

Pfizer to supply up to 6 million Paxlovid treatments to Global Fund

Abbott announces quarterly common dividend

AbbVie announces quarterly cash dividend

Common and Affordable Drug Can Drastically Reduce COVID Complications, Study Shows

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2023